The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease

被引:509
作者
Holmes, DIR
Zachary, I
机构
[1] UCL, BHF Labs, London WC1E 6JJ, England
[2] UCL, Dept Med, Rayne Inst, London WC1E 6JJ, England
[3] Ark Therapeut Ltd, London W1T 6DE, England
关键词
D O I
10.1186/gb-2005-6-2-209
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Vascular endothelial growth factors (VEGFs) are a family of secreted polypeptides with a highly conserved receptor-binding cystine-knot structure similar to that of the platelet-derived growth factors. VEGF-A, the founding member of the family, is highly conserved between animals as evolutionarily distant as fish and mammals. In vertebrates, VEGFs act through a family of cognate receptor tyrosine kinases in endothelial cells to stimulate blood-vessel formation. VEGF-A has important roles in mammalian vascular development and in diseases involving abnormal growth of blood vessels; other VEGFs are also involved in the development of lymphatic vessels and disease-related angiogenesis. Invertebrate homologs of VEGFs and VEGF receptors have been identified in fly, nematode and jellyfish, where they function in developmental cell migration and neurogenesis. The existence of VEGF-like molecules and their receptors in simple invertebrates without a vascular system indicates that this family of growth factors emerged at a very early stage in the evolution of multicellular organisms to mediate primordial developmental functions.
引用
收藏
页数:10
相关论文
共 61 条
[11]   Developmental control of blood cell migration by the Drosophila VEGF pathway [J].
Cho, NK ;
Keyes, L ;
Johnson, E ;
Heller, J ;
Ryner, L ;
Karim, F ;
Krasnow, MA .
CELL, 2002, 108 (06) :865-876
[12]   The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1 [J].
Christinger, HW ;
Fuh, G ;
de Vos, AM ;
Wiesmann, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (11) :10382-10388
[13]   Guidance of cell migration by the Drosophila PDGF/VEGF receptor [J].
Duchek, P ;
Somogyi, K ;
Jékely, G ;
Beccari, S ;
Rorth, P .
CELL, 2001, 107 (01) :17-26
[14]   VASCULARIZATION OF THE MOUSE EMBRYO - A STUDY OF FLK-1, TEK, TIE, AND VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION DURING DEVELOPMENT [J].
DUMONT, DJ ;
FONG, GH ;
PURI, MC ;
GRADWOHL, G ;
ALITALO, K ;
BREITMAN, ML .
DEVELOPMENTAL DYNAMICS, 1995, 203 (01) :80-92
[15]   Cardiovascular failure in mouse embryos deficient in VEGF receptor-3 [J].
Dumont, DJ ;
Jussila, L ;
Taipale, J ;
Lymboussaki, A ;
Mustonen, T ;
Pajusola, K ;
Breitman, M ;
Alitalo, K .
SCIENCE, 1998, 282 (5390) :946-949
[16]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[17]   Solution structure of the heparin-binding domain of vascular endothelial growth factor [J].
Fairbrother, WJ ;
Champe, MA ;
Christinger, HW ;
Keyt, BA ;
Starovasnik, MA .
STRUCTURE WITH FOLDING & DESIGN, 1998, 6 (05) :637-648
[18]   Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer [J].
Ferrara, N ;
Hillan, KJ ;
Gerber, HP ;
Novotny, W .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) :391-400
[19]   The biology of VEGF and its receptors [J].
Ferrara, N ;
Gerber, HP ;
LeCouter, J .
NATURE MEDICINE, 2003, 9 (06) :669-676
[20]   Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442